These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1966571)
21. Ligand binding and platelet uptake studies of loxapine, amoxapine and their 8-hydroxylated derivatives. Fulton A; Norman T; Burrows GD J Affect Disord; 1982 Jun; 4(2):113-9. PubMed ID: 6213689 [TBL] [Abstract][Full Text] [Related]
22. Unusual acute effects of antidepressants and neuroleptics on S2-serotonergic receptors. Helmeste DM; Tang SW Life Sci; 1983 Dec; 33(25):2527-33. PubMed ID: 6139734 [TBL] [Abstract][Full Text] [Related]
23. Investigation of the disposition of loxapine, amoxapine and their hydroxylated metabolites in different brain regions, CSF and plasma of rat by LC-MS/MS. Wong YC; Wo SK; Zuo Z J Pharm Biomed Anal; 2012 Jan; 58():83-93. PubMed ID: 21993198 [TBL] [Abstract][Full Text] [Related]
24. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549 [TBL] [Abstract][Full Text] [Related]
25. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. Millan MJ; Maiofiss L; Cussac D; Audinot V; Boutin JA; Newman-Tancredi A J Pharmacol Exp Ther; 2002 Nov; 303(2):791-804. PubMed ID: 12388666 [TBL] [Abstract][Full Text] [Related]
27. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat. Fone KC; Austin RH; Topham IA; Kennett GA; Punhani T Br J Pharmacol; 1998 Apr; 123(8):1707-15. PubMed ID: 9605579 [TBL] [Abstract][Full Text] [Related]
28. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558 [TBL] [Abstract][Full Text] [Related]
29. Multiple serotonin receptors and their physiological significance. Peroutka SJ; Snyder SH Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063 [TBL] [Abstract][Full Text] [Related]
30. [Desipramine-induced down regulation of beta-adrenergic receptors: effects of noradrenergic and serotonergic neuronal activities and of alpha 2-adrenergic receptor mediated mechanisms]. Matsubara S Hokkaido Igaku Zasshi; 1987 Mar; 62(2):301-10. PubMed ID: 3038720 [TBL] [Abstract][Full Text] [Related]
31. Influence of supidimide on brain neurotransmitter systems of rats and mice. Hennies HH; Günzler WA; Flohé L Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511 [TBL] [Abstract][Full Text] [Related]
33. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. Leysen JE; Janssen PM; Megens AA; Schotte A J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908 [TBL] [Abstract][Full Text] [Related]
34. Affinity of Iresine herbstii and Brugmansia arborea extracts on different cerebral receptors. Nencini C; Cavallo F; Bruni G; Capasso A; De Feo V; De Martino L; Giorgi G; Micheli L J Ethnopharmacol; 2006 May; 105(3):352-7. PubMed ID: 16406412 [TBL] [Abstract][Full Text] [Related]
35. Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain. Lee T; Tang SW Psychiatry Res; 1984 Aug; 12(4):277-85. PubMed ID: 6239298 [TBL] [Abstract][Full Text] [Related]
36. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex. Andree TH; Mikuni M; Tong CY; Koenig JI; Meltzer HY J Neurochem; 1986 Jan; 46(1):191-7. PubMed ID: 2866233 [TBL] [Abstract][Full Text] [Related]
37. Amoxapine: neuroleptic as well as antidepressant? Cohen BM; Harris PQ; Altesman RI; Cole JO Am J Psychiatry; 1982 Sep; 139(9):1165-7. PubMed ID: 6126130 [TBL] [Abstract][Full Text] [Related]
38. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat. Assie MB; Charveron M; Palmier C; Puozzo C; Moret C; Briley M Neuropharmacology; 1992 Feb; 31(2):149-55. PubMed ID: 1313158 [TBL] [Abstract][Full Text] [Related]
39. Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia. Singh AN; Barlas C; Saeedi H; Mishra RK J Psychiatry Neurosci; 2003 Jan; 28(1):39-47. PubMed ID: 12587849 [TBL] [Abstract][Full Text] [Related]
40. Down-regulation of serotonin2, but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and beta-adrenergic receptors. Scott JA; Crews FT Neuropharmacology; 1986 Dec; 25(12):1301-6. PubMed ID: 3031528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]